Parathyroid hormone - A drug for orthopedic surgery?

Acta Orthopaedica Scandinavica

Volumn 75, Issue 6, 2004, Pages 654-662

  Skripitz, Ralf ^a   Aspenberg, Per ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ANIMAL MODEL; BONE DENSITY; BONE MASS; CELL ACTIVITY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; FRACTURE; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE REDUCTION; IMPLANT; ORTHOPEDIC SURGERY; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; REVIEW;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; FRACTURE HEALING; HUMANS; ORTHOPEDIC PROCEDURES; OSTEOGENESIS; OSTEOPOROSIS; PARATHYROID HORMONE; PROSTHESIS FAILURE;

EID: 10944254053     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470410004012     Document Type: Review

References (76)

1. Andreassen T T, Jorgensen P H, Flyvbjerg A, Orskov L, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 1995; 10: 1057-67.
2. Andreassen T T, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 1999; 14 (6): 960-8.
3. Andreassen T T, Fledelius C, Ejersted C, Oxlund H. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand 2001; 72 (3): 304-7.
4. Arnaud C D Jr., Tenenhouse A M, Rasmussen H. Parathyroid hormone. Annu Rev Physiol 1967; 29: 349-72.
5. Bellido T, Ali A A, Plotkin L I, Fu Q, Gubrij I, Roberson P K, Weinstein R S, O'Brien C A, Manolagas S C, Jilka R L. Proteasomal degrdation of Runx2 shortens PTH-induced anti-apoptotic signaling in osteoblasts: A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 2003; 278: 50259-72.
6. Body J J, Gaich G A, Scheele W H, Kulkarni P M, Miller P D, Peretz A, Dore R K, Correa-Rotter R, Papaioannou A, Cumming D C, Hodsman A B. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2002; 87 (10): 4528-35.
7. Bostrom M P, Gamradt S C, Asnis P, Vickery B H, Hill E, Avnur Z, Waters R V. Parathyroid hormone-related protein analog RS-66271 is an effective therapy for impaired bone healing in rabbits on corticosteroid therapy. Bone 2000; 26 (5): 437-42.
8. Canalis E. Systemic and local factors and the maintenance of bone quality. Calcif Tissue Int (Suppl 1) 1993; 53: S90-2; discussion S92-3.
9. Canalis E, Centrella M, Burch W, McCarthy T L. Insulin-like Growth Factor 1 mediates selective anabolic effects of Parathyroid Hormone in bone cultures. J Clin Invest 1989; 83: 60-5.
10. Centrella M, McCarthy T L, Canalis E. Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. Proc Natl Acad Sci U S A 1988; 85 (16): 5889-93.
11. Cosman F, Lindsay R. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 1998; 62 (6): 475-80.
12. Danielsen C C, Mosekilde L, Svenstrup B. Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int 1993; 52 (1): 26-33.
13. Dempster D W, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid hormone on bone (published erratum appears in Endocr Rev 1994; 15 (2):261). Endocr Rev 1993; 14 (6): 690-709.
14. Dempster D W, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid hormone on bone (published erratum appears in Endocr Rev 1994; 15 (2):261). Endocr Rev 1993; 14 (6): 690-709.
15. Dempster D W, Birchman R, Xu R, Lindsay R, Shen V. Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 1995; 16 (1): 157-61.
16. Dempster D W, Cosman F, Kurland E S, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001; 16 (10): 1846-53.
17. Dobnig H, Turner R T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 1995; 136 (8): 3632-8.
18. Frost H M, Jee W S. On the rat model of human osteopenias and osteoporoses. Bone Miner 1992; 18 (3): 227-36.
19. Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, Takahashi H E, Yamamoto K, Fukunaga M. Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int 1999; 9 (4): 296-306.
20. Gera I, Hock J M, Gunness-Hey M, Fonseca J, Raisz L G. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats. Calcif Tissue Int 1987; 40 (4): 206-11.
21. Gunness-Hey M, Hock J M. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Relat Res 1984; 5 (4): 177-81.
22. Gunness-Hey M, Gera I, Fonseca J, Raisz L G, Hock J M. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Calcif Tissue Int 1988; 43 (5): 284-8.
23. Halloran B P, Bikle D D, Harris J, Tanner S, Curren T, Morey-Holton E. Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading. J Bone Miner Res 1997; 12 (7): 1068-74.
24. Hilding M, Ryad L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration-A randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000; 71 (6): 553-7.
25. Hock J M, Gera I, Fonseca J, Raisz L G. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 1988; 122 (6): 2899-904.
26. Hock J M, Hummert J R, Boyce R, Fonseca J, Raisz L G. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo. J Bone Miner Res 1989; 4 (3): 449-58.
27. Hodsman A B, Fraher L J, Watson P H, Ostbye T, Stitt L W, Adachi J D, Taves D H, Drost D. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 1997; 82 (2): 620-8.
28. Holzer G, Majeska R J, Lundy M W, Hartke J R, Einhom T A. Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop 1999; (366): 258-63.
29. Jahng J S, Kim H W. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics 2000; 23 (10): 1089-94.
30. Jilka R L, Weinstein R S, Bellido T, Roberson P, Parfitt A M, Manolagas S C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999; 104 (4): 439-46.
31. Kalu D N, Doyle F H, Pennock J, Denys-Matrajt H, Foster G V. Anabolic effect of parathyroid hormone on bone in the rat. Calcif Tissue Res (Suppl 72) 1970.
32. Kim H W, Jahng J S, Park B M. Effect of recombinant human (1-84) parathyroid hormone on fracture healing in ovariectomized rats. Trans Orthop Res Soc 1997; 22 (22): 181.
33. Kishi T, Hagino H, Kishimoto H, Nagashima H. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration. Bone 1998; 22 (5): 515-22.
34. Leaffer D, Sweeney M, Kellerman L A, Avnur Z, Krstenansky J L, Vickery B H, Caulfield J P. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology 1995; 136 (8): 3624-31.
35. Li X J, Jee W S, Ke H Z, Mori S, Akamine T. Age-related changes of cancellous and cortical bone histomorphometry in female Sprague-Dawley rats. Cells and Materials 1991; 1: S25-S35.
36. Li M, Liang H, Shen Y, Wronski T J. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. Bone 1999; 24 (2): 95-100.
37. Liang J D, Hock J M, Sandusky G E, Santerre R F, Onyia J E. Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1-34. Calcif Tissue Int 1999; 65 (5): 369-73.
38. Lindsay R, Nieves J, Henneman E, Shen V, Cosman F. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients. J Clin Endocrinol Metab 1993; 77 (6): 1535-9.
39. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997; 350 (9077): 550-5.
40. McCarthy T L, Centrella M, Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1989; 124 (3): 1247-53.
41. Meng X W, Liang X G, Birchman R, Wu D D, Dempster D W, Lindsay R, Shen V. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res 1996; 11 (4): 421-9.
42. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhom T A, Yamazaki M. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002; 17 (11): 2038-47.
43. Neer M, Slovik D M, Daly M, Potts T Jr., Nussbaum S R. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int (Suppl 1) 1993; 3: 204-5.
44. Neer R M, Arnaud C D, Zanchetta J R, Prince R, Gaich G A, Reginster J Y, Hodsman A B, Eriksen E F, Ish-Shalom S, Genant H K, Wang O, Mitlak B H. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344 (19): 1434-41.
45. Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S, Takahashi H E. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 1994; 15 (6): 717-23.
46. Onyia J E, Bidwell J, Herring J, Hulman J, and Hock J M. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 1995; 17 (5): 479-84.
47. Parfitt A M. Bone and plasma calcium homeostasis. Bone (Suppl 1) 1987; 8: S1-8.
48. Qi H, Li M, Wronski T J. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Miner Res 1995; 10 (6): 948-55.
49. Rasmussen P. (The role of bone tissue in calcium homeostasis). Nor Tannlaegeforen Tid 1968; 78 (10): 713-25.
50. Reeve J, Hesp R, Williams D, Hulme P, Klenerman L, Zanelli J M, Darby A J, Tregear G W, Parsons J A. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1976a; 1 (7968): 1035-8.
51. Reeve J, Tregear G W, Parsons J A. Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis. Calcif Tissue Res (Suppl) 1976b; 21: 469-77.
52. Reeve J, Meunier P J, Parsons J A, Bernat M, Bijvoet O L, Courpron P, Edouard C, Klenerman L, Neer R M, Renier J C, Slovik D, Vismans F J, Potts J T, Jr. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980; 280 (6228): 1340-4.
53. Reeve J, Davies U M, Hesp R, McNally E, Katz D. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride (published erratum appears in BMJ 1990; 301 (6750): 477). BMJ 1990; 301 (6747): 314-8.
54. Reeve J, Davies U M, Hesp R, McNally E, Katz D. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride (published erratum appears in BMJ 1990; 301 (6750): 477). BMJ 1990; 301 (6747): 314-8.
55. Reeve J, Bradbeer J N, Arlot M, Davies U M, Green J R, Hampton L, Edouard C, Hesp R, Hulme P, Ashby J P, et al. hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses. Osteoporos Int 1991; 1 (3): 162-70.
56. Rodan G A, Martin T J. Therapeutic approaches to bone diseases. Science 2000; 289 (5484): 1508-14.
57. Seebach C, Skripitz R, Andreasen T T, Aspenberg P. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 2004; In press
58. Selye H. On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol. Endocrinology 1932; 16: 547-58.
59. Shen V, Dempster D W, Mellish R W, Birchman R, Horbert W, Lindsay R. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia. Calcif Tissue Int 1992; 50 (3): 214-20.
60. Shen V, Dempster D W, Birchman R, Xu R, Lindsay R. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 1993; 91 (6): 2479-87.
61. Shen V, Birchman R, Xu R, Otter M, Wu D, Lindsay R, Dempster D W. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats. J Clin Invest 1995; 96 (5): 2331-8.
62. Shen V, Birchman R, Wu D D, Lindsay R. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion. J Bone Miner Res 2000; 15 (4): 740-6.
63. Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001a; 83 (3): 437-40.
64. Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop 2001a; (392): 427-32.Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001b; 83 (3): 437-40.
65. Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop 2001a; (392): 427-32.Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg (Br) 2001b; 83 (3): 437-40.
66. Skripitz R, Aspenberg P. Parathyroid hormone (1-34) increases attachment of PMMA cement to bone. J Orthop Sci 2001c; 6 (6): 540-4.
67. Skripitz R, Andreassen T T, Aspenberg P. Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study. J Bone Joint Surg (Br) 2000a; 82 (1): 138-41.
68. Skripitz R, Andreassen T T, Aspenberg P. Strong effect of PTH (1-34) on regenerating bone: a time sequence study in rats. Acta Orthop Scand 2000b; 71 (6): 619-24.
69. Sogaard C H, Wronski T J, McOsker J E, Mosekilde L. The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates. Endocrinology 1994; 134 (2): 650-7.
70. Spencer E M, Si E C, Liu C C, Howard G A. Parathyroid hormone potentiates the effect of insulin-like growth factor-I on bone formation. Acta Endocrinol (Copenh) 1989; 121 (3): 435-42.
71. Tam C S, Heersche J N, Murray T M, Parsons J A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 1982; 110 (2): 506-12.
72. Van Dyke D. Similarity in distribution of skeletal blood flow and erythropoietic marrow. Clin Orthop 1967; 52 (52): 37-51.
73. Watson P, Lazowski D, Han V, Fraher L, Steer B, Hodsman A. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 1995; 16 (3): 357-65.
74. Watson P H, Fraher L J, Kisiel M, DeSousa D, Hendy G, Hodsman A B. Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat. Bone 1999; 24 (2): 89-94.
75. Wronski T J, Smith J M, Jee W S. Variations in mineral apposifion rate of trabecular bone within the beagle skeleton. Calcif Tissue Int 1981; 33 (6): 583-6.
76. Zhang L, Takahashi H E, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M. Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 1997; 21 (6): 501-6.